IVELISSE ZIMA: Open Payments
NPI 1306938816 · CRETE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: Kerendia, CAPLYTA, JOURNAVX, JARDIANCE, MOUNJARO, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
